It could be a leak, or it could be nothing in particular.
Since OCRX reported the negative STOP-HE results in Jan 2017, the share price has swung between $0.52 and $1.94 (a range of almost 4x!) on objectively minor changes in the company’s prospects.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.